SPL
INBX icon

Superior Planning, LLC’s Inhibrx INBX Stock Holding History

Superior Planning, LLC’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3K Buy
+30
New +$2.99K ﹤0.01% 1409

Other funds holding INBX

Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Capitolis Liquid Global Markets
Capitolis Liquid Global Markets New York $22.4B AUM 40.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Superior Planning, LLC's INBX Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Inhibrx (INBX) in Q3 2026: 30 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #1409 among its holdings.

89 funds tracked by Wall St. Rank hold INBX as of Q3 2026.

  • Superior Planning, LLC held 30 shares of Inhibrx worth $3K as of Q3 2026.
  • Inhibrx was a new Superior Planning, LLC position in Q3 2026.
  • Inhibrx made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1409 holding.
  • 89 funds tracked by Wall St. Rank held Inhibrx as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.